Skip to main content
. 2015 Mar 4;10(3):e0118830. doi: 10.1371/journal.pone.0118830

Table 2. Association between endogenous expression of IFN-β-inducible genes in peripheral blood mononuclear cells with T-cell reactivity to myelin basic protein (MBP) and tetanus toxoid (TT) in untreated MS patients.

Gene expression ratio (MBP responders/ non-responders) a IFN-ß treatment induced changes in gene expression b Gene expression ratio (TT proliferation high/ low) c
Representative public ID Gene symbol Expression ratio P-value Gene expression FDR Gene expression P-value
AA393940 --- 2,38983 0,00004 1,05436 0,71439 0,65885 0,07972
AF127481 --- 0,66090 0,00568 0,80634 0,23709 1,72837 0,09079
AL527773 ABR 0,60767 0,00796 0,94413 0,44159 0,79811 0,44018
S69189 ACOX1 0,60974 0,00695 0,85280 0,13347 0,73019 0,19905
NM_006395 ATG7 0,53188 0,00587 1,20249 0,00433 0,71277 0,30945
U72937 ATRX 0,65347 0,00415 0,72367 0,00094 0,65718 0,12609
AB035482 C1orf38 0,65053 0,00801 1,63014 0,00000 0,80314 0,38388
U62027 C3AR1 0,59222 0,00348 2,64914 0,00001 0,68092 0,19756
U47924 CD4 0,62806 0,00558 0,92128 0,56399 0,74489 0,22181
NM_001784 CD97 0,64874 0,00816 1,35297 0,00026 0,78190 0,32496
AL564683 CEBPB 0,63381 0,00476 1,50631 0,00014 0,77715 0,08505
NM_005195 CEBPD 0,63337 0,00417 1,61098 0,00140 0,77148 0,30036
NM_006090 CEPT1 0,51559 0,00032 1,05430 0,64946 0,67176 0,16979
NM_000760 CSF3R 0,56506 0,00785 1,56528 0,00008 0,76494 0,36178
NM_004383 CSK 0,50162 0,00561 1,12576 0,18584 0,55615 0,14777
N25915 CUGBP1 0,49958 0,00484 0,74453 0,03732 0,55201 0,15624
NM_004417 DUSP1 0,44522 0,00398 1,52685 0,00020 0,56529 0,11542
NM_001953 ECGF1 0,51953 0,00732 4,53205 0,00002 1,12746 0,76894
BC000533 EIF3S8 0,63224 0,00664 0,79373 0,01835 0,74438 0,35954
NM_012177 FBXO5 0,66612 0,00629 0,85859 0,27780 0,58712 0,00558
AW001443 GGA1 0,49321 0,00502 0,70943 0,00408 0,64771 0,26468
AW009695 GGA1 0,48944 0,00551 0,70032 0,00746 0,60170 0,24124
NM_004126 GNG11 1,53490 0,00020 0,81936 0,01488 1,25208 0,25286
BC000324 GRN 0,60910 0,00900 2,15801 0,00000 0,96352 0,88274
NM_022460 HS1BP3 0,61000 0,00873 1,09055 0,26549 0,78109 0,25038
AF141870 ILF3 0,46941 0,00869 0,73496 0,03630 0,52984 0,16518
NM_002199 IRF2 0,61305 0,00405 2,13032 0,00042 0,62974 0,12245
NM_006084 ISGF3G 0,65931 0,00629 1,48177 0,00002 0,81538 0,35916
NM_002229 JUNB 0,42768 0,00074 2,00080 0,00000 0,54768 0,06116
NM_005354 JUND 0,58269 0,00860 1,34615 0,01096 0,63146 0,21424
NM_007054 KIF3A 0,62358 0,00228 0,62132 0,00137 0,64832 0,01398
NM_016285 KLF12 0,60366 0,00182 0,67407 0,00478 0,63583 0,06954
BF514079 KLF4 0,59463 0,00091 1,32022 0,00059 0,71383 0,12362
NM_005461 MAFB 0,60432 0,00356 3,03565 0,00000 0,72817 0,20138
NM_002406 MGAT1 0,55525 0,00223 1,45918 0,00004 0,70792 0,19953
NM_005931 MICB 0,62026 0,00773 1,05054 0,69661 0,62686 0,12993
NM_014381 MLH3 1,55617 0,00037 0,98685 0,89715 1,30512 0,22600
NM_012331 MSRA 0,66622 0,00478 0,95432 0,51950 0,74943 0,08485
NM_017458 MVP 0,55557 0,00277 1,89293 0,00000 0,73133 0,26680
U70451 MYD88 0,57903 0,00055 1,91913 0,00000 0,73916 0,17010
NM_002505 NFYA 0,49007 0,00928 0,92316 0,55970 0,48639 0,13324
NM_013392 NRBP1 0,52913 0,00542 1,05099 0,58002 0,70485 0,30052
AI824012 NRIP1 0,53985 0,00219 1,67004 0,00233 0,60243 0,08224
NM_002534 OAS1 0,40953 0,00229 6,83506 0,00000 0,62769 0,25810
NM_016817 OAS2 0,54858 0,00293 4,85365 0,00000 0,77768 0,43984
NM_006187 OAS3 0,56192 0,00701 7,09851 0,00000 0,79581 0,45168
AF242521 OAZ2 0,62811 0,00292 1,11296 0,05416 0,78569 0,35423
NM_023914 P2RY13 0,53025 0,00107 1,61084 0,00057 0,74296 0,25271
NM_002656 PLAGL1 0,71437 0,01698 1,23990 0,07508 0,59712 0,00765
NM_018444 PPM2C 0,55737 0,00865 0,89289 0,33921 0,67981 0,24250
NM_007318 PSEN1 0,61678 0,00925 1,05178 0,46844 0,66741 0,15644
NM_002806 PSMC6 0,79988 0,16321 0,79397 0,00226 0,66459 0,00427
NM_002872 RAC2 0,66609 0,00465 0,96417 0,69396 0,68330 0,08692
NM_002902 RCN2 0,81450 0,11315 0,50180 0,00001 0,60390 0,00465
AI263909 RHOB 0,37747 0,00029 3,49399 0,00001 0,55096 0,10617
NM_012249 RHOQ 0,59453 0,00037 1,13092 0,19030 0,71506 0,14372
BE897886 RHOQ 0,54734 0,00163 1,06784 0,42048 0,56116 0,07599
NM_002939 RNH1 0,52587 0,00221 1,44191 0,00004 0,92825 0,81932
NM_000979 RPL18 1,50894 0,00011 0,69713 0,00006 1,33955 0,02902
NM_003942 RPS6KA4 0,58647 0,00545 1,30240 0,05970 0,71857 0,34645
AI871457 SFRS8 0,77329 0,02205 0,74400 0,00536 0,64223 0,00582
NM_005627 SGK 0,56251 0,00198 0,67001 0,00243 0,73625 0,28065
NM_020979 SH2B2 0,62734 0,00053 1,65552 0,00000 0,80701 0,28688
AI025519 SLC26A2 0,58834 0,00438 0,62356 0,00097 0,62053 0,13411
AA524345 SNX4 0,65104 0,00840 0,87639 0,20487 0,61664 0,07937
X15132 SOD2 0,67714 0,03673 1,60177 0,00032 0,56143 0,00801
AL442077 SPFH2 0,62805 0,00197 0,88592 0,12560 0,69761 0,07905
M97935 STAT1 0,54867 0,00826 2,23157 0,00000 0,69476 0,32416
NM_005131 THOC1 0,64186 0,00742 0,56570 0,00006 0,61169 0,06322
NM_003266 TLR4 0,61293 0,00465 1,45846 0,00045 0,68766 0,14945
NM_016610 TLR8 0,51446 0,00730 1,18074 0,08572 0,63275 0,25378
NM_001243 TNFRSF8 0,59619 0,00229 0,94210 0,62315 0,70852 0,17841
NM_025195 TRIB1 0,57316 0,00247 1,77640 0,00045 0,61108 0,07589
AI363270 TRIM38 0,61895 0,00611 1,45895 0,00016 0,65750 0,16616
NM_030912 TRIM8 0,64113 0,00047 1,11388 0,23857 0,76183 0,12478
NM_007124 UTRN 0,55447 0,00563 1,07708 0,47925 0,57623 0,09694
NM_004184 WARS 0,55612 0,00991 3,98419 0,00000 0,92506 0,81254
NM_014795 ZFHX1B 0,56386 0,00468 1,16480 0,31749 0,52589 0,06223
NM_003407 ZFP36 0,54741 0,00230 1,42917 0,00657 0,59914 0,09480
BG250310 ZFP36L1 0,62283 0,00140 1,05199 0,61205 0,65364 0,10535

(a) In a previous study, 4 out of 17 patients responded to MBP with CD4+ T-cell proliferation ex vivo [21]. By DNA array analysis of gene expression [18], we found that 75 out of 3284 genes were more than 1.5-fold differentially expressed (p<0.01) in the 4 patients who had CD4+ T-cell reactivity to MBP as compared to the 13 patients who did not show CD4+ T-cell reactivity to MBP (differentially expressed genes are highlighted with bold letters). Data were obtained from the substudy-1 population and are given as ratio of the mean gene expression in both groups.

(b) We compared these results with data on IFN-β treatment-induced gene-expression levels in 23 patients from a recent study from our group [22]: 23 out of the 75 (31%) genes differentially expressed in patients with MBP-induced T-cell proliferation were induced at least 1.5-fold in patients treated with IFN-β (false discovery rate< 1% for all genes). Out of the remaining 3209 genes 171 (5.3%) were similarly induced after treatment with IFN-β (X2 = 84.64, df = 1, p<0.001).

(c) Data on TT reactivity were available from 12 patients from the sub-study 1 population [21]. Dividing the patients into two groups according to the level of TT reactivity (6 TT high responders vs. 6 TT low responders), we calculated the gene-expression ratio and identified 6 genes that were more than 1.5-fold differentially expressed (p<0.01; bold letters). (b) 4 out of these 6 genes were also significantly regulated by treatment with IFN-β, although only one of these genes was induced more than 1.5-fold.